Singapore, 8 - 10 December 2020
Schedule
Create your personal agenda –check the favourite icon
Dec 809:00
Conference pass
Keynote Panel: The digital opportunity for pharma– New technology, new investments, new opportunities
Keynotes
Dec 810:00
Conference pass
Keynote Panel: Creating a collaborative drug development ecosystem
Keynotes
Vishal Doshi, Chief Executive Officer, AUM BiosciencesSingapore
Raymond Stevens, CEO and Co-founder, ShouTi PharmaChina
Kevin Chen, CEO, ElixironTaiwan
Dec 811:00
Conference pass
Drug development – critical need to move beyond single agent therapy
Immunotherapy
Dec 811:00
Conference pass
Enleofen Bio: First-in-class therapeutics for fibro-inflammatory diseases (preclinical)
Clinical Trials
Dec 811:30
Conference pass
ATL1102 for Duchenne muscular dystrophy (DMD)
Immunotherapy
Dec 811:30
Conference pass
Moving from conventional clinical trials to adaptive clinical trials
Clinical Trials
John Patava, Chief Operating Officer, AUM BiosciencesSingapore
Dec 812:00
Conference pass
Gene and Cell Therapy Outsourcing Success Factors
Immunotherapy
Dec 812:00
Conference pass
Challenges in development of biosimilars and biosimilarity assessment – statistical perspective
Clinical Trials
Sophie Tsou, Associate Investigator, Division Of Biostatistics And Bioinformatics, National Health Research InstitutesTaiwan
Dec 812:30
Conference pass
Panel: Partnering for the next immuno-oncology breakthrough
Immunotherapy
Moderator: Prof Cristina Stefan, Consultant, Institute of Oncology, Adjunct Associate Professor, SingHealth Duke-NUS Global Health Institute (SDGHI)Singapore
Diana Bonilla, Technical Application Specialist (US), Cytek Biosciences, Inc.United States
Ying Pan, Senior Director, Translational Medicine and Biomarker, CStoneChina
Dec 812:30
Conference pass
Global industry adopted clinical project management competencies
Clinical Trials
Dec 813:00
Conference pass
Singapore’s cancer clinical trials ecosystem – Challenges and solutions for stakeholders
Clinical Trials
Dec 813:30
Conference pass
HBV-specific TCR-T Cell Therapy in Hepatocellular Carcinoma
Immunotherapy
Dec 813:30
Conference pass
Panel: Clinical trials in China
Clinical Trials
Dr Daniel Liu, Chief Scientific Officer, Clinical Service CenterChina
Joe Zhang, CEO, BJ Bioscience Inc.China
Da Liu, Managing Director, China Resources Life Science FundHong Kong
Dec 814:00
Conference pass
Driving immuno-oncology with rational antibody discovery
Immunotherapy
Dec 814:30
Conference pass
Multifunctional antibodies and immunotherapy
Immunotherapy
Ignacio Asial, Founder And Chief Executive Officer, DotBioSingapore
Dec 814:30
Conference pass
Panel: Partnering to improve quality in clinical trials
Clinical Trials
Hyejin Shin, Director, Group Leader, Clinical Qa, Samsung BioepisRepublic Of Korea
Sunil Pandita, Manager Clinical Quality Assurance, Abbott LabSingapore
Dec 815:00
Conference pass
Humanized mouse model: A tool to address human specific questions in biomedical research
Immunotherapy
Dec 815:30
Conference pass
Organ-on-a-chip models for research, drug development and diagnostics
Immunotherapy
Chee Mun Kuan, Executive Director and Co-Founder, AIM Biotech Pte LtdSingapore
Dec 815:30
Conference pass
Panel: Transforming clinical trials with technology
Clinical Trials
Dec 816:00
Conference pass
Development of cGMP Manufacturing Platforms for Cellular Immunotherapies: MSCs, NK cells and T cells
Immunotherapy
Kaushik Deb, CEO, DiponEd BioIntelligenceIndia
Dec 816:30
Conference pass
Molecular insights into key mechanistic steps of an adaptive immune response
Immunotherapy
Dec 816:30
Conference pass
Panel: The future of clinical trials in Asia
Clinical Trials
Moderator: Shubhangi Desai, Director Clinical Trial Management, AbbottSingapore
Dec 817:00
Conference pass
Clinical grade Asian human induced pluripotent stem cell-derived beta cells for diabetes therapy: Innovative Cell Therapy Platform for Asian Diabetes
Immunotherapy
Create your personal agenda –check the favourite icon
Dec 909:00
Conference pass
Keynote Panel: Fostering innovation through partnerships
Keynotes
Moderator: Rajendra Srivastava, Dean and Novartis Professor of Marketing Strategy and Innovation, Indian School Of BusinessIndia
Anand Gautam, Executive Director & Emerging Science Lead, Emerging Science & Innovation (ES&I), Asia & Asia-Pacific (ANZ), Pfizer Worldwide R&DAustralia
Vern De Biasi, Vice President, Global Head of Strategic Partnerships, Cyclica Inc.Canada
Damian O'Connell, Chief Executive Officer Experimental Drug Development Centre, A*STARSingapore
Dec 910:00
Conference pass
Accelerating antibody engineering and discovery using synthetic libraries
Pharma 4.0
Dec 910:00
Conference pass
Overview of IND/NDA process in China
Market Access & Pricing
Dr Daniel Liu, Chief Scientific Officer, Clinical Service CenterChina
Dec 910:00
Conference pass
Dec 910:15
Conference pass
Networking break
Biotech Invest
Networking breaks
Dec 910:30
Conference pass
Panel: Partnering for the future
Pharma 4.0
Moderator: Philip McCloud, Director and Principal Statistician, McCloud Consulting Group Pty LtdAustralia
James Garner, Chief Executive Officer, Kazia Therapeutics LimitedAustralia
Kevin Lei, Business Development Manager, AtomwiseUnited States
Dec 910:30
Conference pass
Introduction of medical device regulatory system in Asia – challenges and tips for quicker registration
Market Access & Pricing
Jack Wong, Founder of ARPA, Asia Regulatory Professionals Association and Head of RA, MOW, Biocon BiologicsSingapore
Dec 910:30
Conference pass
Biotech pitch - LaMeditech Co., Ltd.
Biotech Invest
Patrick Jang, CFO, LaMeditech Co., Ltd.Republic Of Korea
Dec 910:45
Conference pass
Dec 911:00
Conference pass
Panel: Adapting to the changing market access landscape
Market Access & Pricing
Finny Liu, APAC Regional Regulatory Policy Lead, Roche Singapore Pte LtdSingapore
Vikas Tripathi, Head - Global Business Development, Polisano PharmaceuticalsSingapore
Dec 911:00
Conference pass
Networking break
Biotech Invest
Networking break
Dec 911:15
Conference pass
Dec 911:30
Conference pass
Neurotech: the next frontier
Pharma 4.0
Charles Stacey, President And Chief Executive Officer, CerecinSingapore
Dec 911:30
Conference pass
Fireside chat: Building a biotech company – Challenges and successes
Biotech Invest
Dave Ng, General Partner, Altara VenturesSingapore
Dec 912:00
Conference pass
Integrating machine learning and combinatorial CRISPR for drug development for the precision medicine paradigm
Pharma 4.0
Jeffrey Lu, Co-Founder And Chief Executive Officer, Engine BiosciencesUnited States
Dec 912:00
Conference pass
Panel: How do we rethink the delivery of universal healthcare – providing equitable access to patients post Covid-19?
Market Access & Pricing
Moderator: Anand Jha, Managing Director, AnseaSingapore
Jek Fong, Director, Patient Access and Personalised Healthcare, RocheSingapore
Dec 912:00
Conference pass
Biotech pitch - X-Zell Biotech Co. Ltd.
Biotech Invest
Sebastian Bhakdi, Founder and CEO, X-Zell Biotech Co. Ltd.Thailand
Dec 912:15
Conference pass
Biotech pitch - ONWARD Health Research
Biotech Invest
Martin Lim, CEO, ONWARD Health ResearchSingapore
Dec 912:30
Conference pass
Dec 913:00
Conference pass
Panel: Fostering homegrown innovation in Southeast Asia – investor & biotech perspectives
Biotech Invest
Yen Choo, Associate Professor, Lee Kong Chian School of MedicineSingapore
Dec 913:30
Conference pass
Synthetic DNA technologies enable antibody discovery and optimization
Pharma 4.0
Dec 913:30
Conference pass
Making antibodies affordable for all
Market Access & Pricing
Pritha Aggarwal, Manager, IAVIIndia
Dec 914:00
Conference pass
Partnerships to accelerate the pipeline
Pharma 4.0
Dec 914:00
Conference pass
Access to care for NCDs: Going big with biosimilars
Market Access & Pricing
Dec 914:00
Conference pass
Biotech pitch - KrossLinker
Biotech Invest
Dec 914:15
Conference pass
Biotech pitch - Revivo Biosystems
Biotech Invest
Dec 914:30
Conference pass
Personalized Healthcare - Enabling a Next Generation Healthcare Ecosystem to Accelerate Patient Access in Singapore
Pharma 4.0
Jek Fong, Director, Patient Access and Personalised Healthcare, RocheSingapore
Dec 914:30
Conference pass
Panel: Treating stakeholders and payers like customers
Market Access & Pricing
Dec 914:30
Conference pass
Biotech pitch - CellProthera Pte Ltd
Biotech Invest
Alexandre Civiere, Project Manager, CellProthera Pte LtdSingapore
Dec 914:45
Conference pass
Fireside chat: The future of Rx + DTx
Biotech Invest
Bechara Saab, Cofounder, Chief Scientist and CEO, Mobio InteractiveSingapore
Gaurav Laroia, Sr. Vice President - Strategy and Head of Business Development, Biocon Biologics India LimitedIndia
Dec 915:00
Conference pass
Using machine learning for effective manufacturing
Pharma 4.0
Dec 915:15
Conference pass
Biopharma today & beyond: Licensing deals, valuations & investment trends
Biotech Invest
Pravin Krishnan, Business Development, Asia Pacific, BiotechgateSingapore
Dec 915:30
Conference pass
CURATE.AI: Finding the optimal drugs and dosage
Pharma 4.0
Dean Ho, Professor and Director, Institute for Digital Medicine (WisDM), National University of SingaporeSingapore
Dec 915:30
Conference pass
Moving from market access to patient access from a payer’s perspective
Market Access & Pricing
Anand Jha, Managing Director, AnseaSingapore
Dec 916:00
Conference pass
How technology is creating new opportunities for patient centricity
Pharma 4.0
Khee Suan Bang, Manager, Digital Activation Strategy, Danone Nutricia ResearchSingapore
Dec 916:00
Conference pass
Forming a collaborative relationship with stakeholders and payers
Market Access & Pricing
Shailendra Bajpai, Global Head Of Disease Management And Key Stakeholder Engagement, Diabetes and CV Emerging Markets, SanofiSingapore
Dec 916:30
Conference pass
Panel: Using digital therapeutics to drive innovation
Pharma 4.0
Dec 917:30
Conference pass
Changing paradigms in drug discovery – combining robotics and AI
Pharma 4.0
Create your personal agenda –check the favourite icon
Dec 1009:00
Conference pass
Panel: Bio-Entrepreneur Journey – Trials and Tribulations on the Path to Success
Biotech Invest
Anthony Desir, Director, Acting CEO and CFO, Moexa Pharmaceuticals LimitedHong Kong
Yen Choo, Associate Professor, Lee Kong Chian School of MedicineSingapore
Dec 1009:30
Conference pass
Next generation of artificial intelligence for drug discovery
BioData
Dec 1010:00
Conference pass
Current and future computing infrastructure of Bioinformatics in Clinical Dx
BioData
Dec 1010:00
Conference pass
Biotech pitch - Kazia Therapeutics Limited
Biotech Invest
James Garner, Chief Executive Officer, Kazia Therapeutics LimitedAustralia
Dec 1010:15
Conference pass
Biotech pitch - Vascular Indonesia
Biotech Invest
Vascular Indonesia
Dec 1010:30
Conference pass
Biocomputational design of synthetic antibodies for molecular applications
BioData
Dec 1010:30
Conference pass
Biotech pitch - Biogenes Technologies Sdn Bhd
Biotech Invest
Adrian Joseph, Co-founder, Biogenes Technologies Sdn BhdMalaysia
Dec 1010:45
Conference pass
Biotech pitch - Advanx Health
Biotech Invest
Yong Wei Shian, Co-Founder And Chief Executive Officer, Advanx HealthMalaysia
Dec 1011:00
Conference pass
Using Real World Evidence and Biomarkers for pharma value creation
BioData
Prayat Shah, Co-founder and VP - Partnerships, Wellthy TherapeuticsIndia
Dec 1011:00
Conference pass
Panel: Accessing capital for scaling up your biotech
Biotech Invest
Vishal Doshi, Chief Executive Officer, AUM BiosciencesSingapore
Sridhar Gopal, Head of Business Development, AbbVieUnited States
Da Liu, Managing Director, China Resources Life Science FundHong Kong
Dec 1011:30
Conference pass
Panel: Future opportunities for pharma and academia to jointly shape healthcare
BioData
Dr Sonali Khanra, Head Innovation & Strategy, OJAS Medtech BioNEST, IIIT HyderabadIndia
Ülo Palm, Cofounder and Chief Medical Officer (CMO), Ordaos BioUnited States
Dec 1012:00
Conference pass
Biotech pitch - MedFluid Co Ltd
Biotech Invest
Dec 1012:15
Conference pass
Biotech pitch - BIFIDO Co., Ltd
Biotech Invest
Startup representative, KHIDI
Myeong Soo Park, CTO, Bifido Co LtdRepublic Of Korea
Dec 1012:30
Conference pass
Biotech pitch - Stratificare
Biotech Invest
Dec 1012:45
Conference pass
Biotech pitch - CureBio Co., Ltd R&D Center
Biotech Invest
Startup Representative, KHIDI
Seo-Yong Cho, CEO, CureBio.Co., Ltd. R&D CenterRepublic Of Korea
Dec 1013:15
Conference pass
Biotech pitch - 3BIGS Co., Ltd
Biotech Invest
Junhyung Park, CEO, 3BIGS CO.,LTDRepublic Of Korea
Dec 1013:30
Conference pass
Biotech pitch - AriBio Co., Ltd
Biotech Invest
Fred Kim, Associate Director, AriBio Co., Ltd.Republic Of Korea
Dec 1013:45
Conference pass
Biotech pitch - QuikPath
Biotech Invest
Dec 1014:00
Conference pass
Panel: Attracting early-stage capital: What are VCs looking for in biotech investments in Asia?
Biotech Invest
Haolin Sung, Managing Partner, Chaperone InvestmentUnited States
last published: 09/Dec/20 03:45 GMT
